The company applies its therapeutic expertise in RNAi to significant medical needs.

Founded in 2002, Alnylam maintains headquarters in Cambridge, Massachusetts. For more information, please visit.. About Alnylam PharmaceuticalsAlnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi-based. The company applies its therapeutic expertise in RNAi to significant medical needs, many of which are not small molecules or antibodies small molecules or antibodies, the current major classes of drugs. Alnylam is leading the translation published by RNAi as a new class of innovative medicines with peer-reviewed research into the world’s leading scientific journals such as Nature, Nature Medicine and Cell.

About RNA Interference RNAi is a revolution in biology that a breakthrough in the understanding, genes genes turned and turned into the cells, and a completely new approach to drug discovery and development. Their discovery was described as ‘a major scientific breakthrough that happens once every decade or so, ‘and represents one of the most promising and rapidly advancing frontiers in biology and in drug discovery today which was awarded the 2006 Nobel Prize for Physiology or Medicine has been announced. RNAi is a natural process of gene silencing in organisms ranging from in organisms ranging from plants to mammals.Prior to the suits have been resolved, CIRM needed no sovereign bonds, was by sale to fund the program, Institute of officer did said. To California Stem Cell Research and cure Finance Committee of in November 2006 approves $ 181,000 term loan to CIRM who order $ 150,000 from national common fund by Gov. Arnold Schwarzenegger and $ 31,000 from private donations (including Kaiser Daily female Policy Health Report, Robert Klein, Chairman of the Independent civil Oversight Committee, said the first to $ 250,000 into bonds issued in July or August, mostly is going to repay the state loans and private donations. The state been $ 158,000 approved in research funding, and view more more than 300 million dollars by the end of of year could be, Klein said (San Francisco Chronicle.

Random entries

Other entries from category "slimming":